Veracity Capital’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-19,782
Closed -$466K 254
2020
Q3
$466K Buy
19,782
+656
+3% +$15.4K 0.13% 166
2020
Q2
$424K Sell
19,126
-1,632
-8% -$33.8K 0.12% 169
2020
Q1
$381K Buy
20,758
+330
+2% +$6.65K 0.11% 132
2019
Q4
$428K Buy
+20,428
New +$405K 0.11% 140

Other funds holding BOUT

Veracity Capital's BOUT Position: Q4 2020 in Review

Veracity Capital sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2020, closing a stake of 19,782 shares — an estimated $466K sold.

Veracity Capital first reported a position in BOUT in Q4 2019 and held it in 4 quarters. The position peaked at $466K in Q3 2020. 10 funds tracked by Wall St. Rank hold BOUT as of Q4 2020.

  • Veracity Capital reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2020 after selling out during the quarter.
  • Veracity Capital sold 19,782 CapForce IBD Breakout Opportunities ETF shares in Q4 2020, an estimated $466K.
  • Veracity Capital first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2019 and held it in 4 quarters.
  • Veracity Capital's CapForce IBD Breakout Opportunities ETF position peaked at $466K in Q3 2020.
  • 10 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2020.

Based on Veracity Capital's 13F filing for Q4 2020, filed 25 Jan 2021.